M N Abbas COSA 2015 ASM

Abstracts this author is presenting:

• Final Report of a Phase I Trial of Lipovaxin-MM, a Novel Dendritic Cell-Targeted Liposomal Vaccine for Malignant Melanoma. — Posters1